Comparative therapeutic effect of steroidal and non-steroidal anti-inflammatory drugs on pro-inflammatory cytokine production in water buffalo calves (Bubalus bubalis) naturally infected with bronchopneumonia: a randomized clinical trial
- PMID: 28831754
- DOI: 10.1007/s11250-017-1383-8
Comparative therapeutic effect of steroidal and non-steroidal anti-inflammatory drugs on pro-inflammatory cytokine production in water buffalo calves (Bubalus bubalis) naturally infected with bronchopneumonia: a randomized clinical trial
Abstract
In the current study, we compared the therapeutic effects of a non-steroidal and a steroidal anti-inflammatory drug on the production of pro-inflammatory cytokines, interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-12p40 (IL-12p40), interferon gamma (IFNγ), and tumor necrosis factor alpha (TNF-α) in the blood of water buffalo (Bubalus bubalis) calves naturally infected by bronchopneumonia. Twenty-seven buffalo calves (7 ± 2-month-old, 163 ± 12 kg) reared in smallholder farms in El-Dakahlia province in Egypt were identified to have bronchopneumonia and randomly allocated into three equal groups. Ten clinically healthy buffalo calves with negative bronchoalveolar lavage results were served as negative control. Diseased calves were treated with tulathromycin alone, a combination of tulathromycin with dexamethasone (steroidal anti-inflammatory drug) or tulathromycin with flunixin meglumine (non-steroidal anti-inflammatory drug). The results revealed significant elevations (P < 0.05) in the production of selected cytokines in all diseased calves in comparison with healthy animals. Six days post-treatment, a significant inhibition (P < 0.05) in the production of all assessed cytokines was observed in the blood of all treated calves. Interestingly, the serum concentrations of IL-1β and IL-12p40 were returned to the normal levels in pneumonic calves treated with the combination therapy of tulathromycin and flunixin meglumine. A strong significant positive correlation (P < 0.05) was detected between clinical sum scoring and IL-12p40 and TNF-α concentrations. The obtained results indicate the selectively potent anti-inflammatory effect of flunixin meglumine on the production of pro-inflammatory cytokines in pneumonic buffalo calves and highlight the efficacy of flunixin meglumine in the treatment of bronchopneumonia in buffalo calves when used in combination with tulathromycin.
Keywords: Bronchopneumonia; Buffalo calves; Cytokines; Dexamethasone; Flunixin meglumine.
Similar articles
-
A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia.Pol J Vet Sci. 2003;6(2):109-15. Pol J Vet Sci. 2003. PMID: 12817781 Clinical Trial.
-
Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia.Vet Microbiol. 2003 Oct 8;96(1):53-67. doi: 10.1016/s0378-1135(03)00203-7. Vet Microbiol. 2003. PMID: 14516708
-
Clinical efficacy of meloxicam (Metacam) and flunixin (Finadyne) as adjuncts to antibacterial treatment of respiratory disease in fattening cattle.Berl Munch Tierarztl Wochenschr. 2004 Jul-Aug;117(7-8):304-9. Berl Munch Tierarztl Wochenschr. 2004. PMID: 15298058 Clinical Trial.
-
Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.J Am Vet Med Assoc. 1989 Jan 1;194(1):45-9. J Am Vet Med Assoc. 1989. PMID: 2644181 Review.
-
ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs.Expert Opin Investig Drugs. 2001 Jul;10(7):1207-9. doi: 10.1517/13543784.10.7.1207. Expert Opin Investig Drugs. 2001. PMID: 11772244 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources